Lipella Pharmaceuticals Inc.(NASDAQ:LIPO) 
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic...
Website: https://www.lipella.com
Founded: 2005
IPO Price: $5.75 (Dec 20, 2022)
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.44
H 2.44
L 2.31
C 2.31
V 17,459
10EMA 2.31
20EMA 2.31
60EMA 2.31
120EMA 2.31
250EMA 2.31